Get the full picture
Sign in to uncover key details.
Helex
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7 Penn Plz Fl 9, New York, New York, 100...Website
helex.bioRevenue
<$5 MillionIndustry
About Helex
Helex is a biotechnology company headquartered in New York, New York, developing genomic medicines for kidney diseases. Founded in 2021, the company focuses on creating gene editing therapeutics specifically designed for renal indications. Helex combines proprietary lipid nanoparticle technology for targeted delivery to the kidney with its Epic-Cure technology platform, which utilizes data-driven deep-learning modeling to design and validate guide RNAs for CRISPR-based gene editing. The platform enables precise drug design by predicting edit outcomes to ensure safety and avoid unwanted editing in non-target cells. The company's therapeutic focus includes Autosomal Dominant Polycystic Kidney Disease as part of its mission to develop therapies for patients suffering from chronic kidney disease.Explore more
Helex Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Helex
Compare insights from companies similar to Helex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Helex Tech Stack
A closer look at the technologies used by Helex
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Helex
Sign Up For FreeTo access detailed company insights
Helex is a biotechnology company headquartered in New York, New York, developing genomic medicines for kidney diseases. Founded in 2021, the company focuses on creating gene editing therapeutics specifically designed for renal indications. Helex combines proprietary lipid nanoparticle technology for targeted delivery to the kidney with its Epic-Cur... Read More
